Geneos Wealth Management’s Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033 SLVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,485
Closed -$283K 2504
2022
Q2
$283K Sell
3,485
-420
-11% -$39.3K 0.01% 634
2022
Q1
$406K Sell
3,905
-142
-4% -$14.7K 0.02% 591
2021
Q4
$411K Sell
4,047
-170
-4% -$17.7K 0.02% 642
2021
Q3
$432K Buy
4,217
+257
+6% +$28.6K 0.02% 611
2021
Q2
$486K Buy
3,960
+1,982
+100% +$251K 0.02% 568
2021
Q1
$247K Buy
1,978
+16
+0.8% +$2.09K 0.01% 882
2020
Q4
$243K Buy
+1,962
New +$250K 0.01% 764
2020
Q2
Sell
-105
Closed -$11K 2615
2020
Q1
$11K Hold
105
﹤0.01% 1786
2019
Q4
$14K Hold
105
﹤0.01% 1850
2019
Q3
$14K Buy
+105
New +$14.9K ﹤0.01% 1767

Other funds holding SLVO

Geneos Wealth Management's SLVO Position: Q3 2022 in Review

Geneos Wealth Management sold out of Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033 (SLVO) in Q3 2022, closing a stake of 3,485 shares — an estimated $283K sold.

Geneos Wealth Management first reported a position in SLVO in Q3 2019 and held it in 10 quarters. The position peaked at $486K in Q2 2021. 19 funds tracked by Wall St. Rank hold SLVO as of Q3 2022.

  • Geneos Wealth Management reported no remaining Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033 position as of Q3 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 3,485 Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033 shares in Q3 2022, an estimated $283K.
  • Geneos Wealth Management first reported a position in Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033 in Q3 2019 and held it in 10 quarters.
  • Geneos Wealth Management's Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033 position peaked at $486K in Q2 2021.
  • 19 funds tracked by Wall St. Rank held Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033 as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.